Hagop Kantarjian: Gamma delta T cells, a novel immunotherapy for AML

Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center,shared a post on X/Twitter:

“Gamma delta T cells are a novel immunotherapy for AML. Recent review from our group. We have clinical trials w Aza Ven and gd2T cell activating ICT01 for Newly Dx AML, & allogeneic gd1T cells for R/R AML”